2013
DOI: 10.1186/1475-9276-12-60
|View full text |Cite
|
Sign up to set email alerts
|

Multi-morbidity of non communicable diseases and equity in WHO Eastern Mediterranean countries

Abstract: IntroductionNon communicable diseases are the biggest cause of death worldwide. Beside mortality, these diseases also cause high rates of morbidity and disability. Their high prevalence is generally associated to multi-morbidity. Because they need costly prolonged treatment and care, non communicable diseases have social and economical consequences that affect individuals, households and the whole society. They raise the equity problem between and within countries.Methods and limitationsThis annotated bibliogr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
86
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 111 publications
(90 citation statements)
references
References 25 publications
3
86
0
Order By: Relevance
“…Obesity is related to increased morbidity and mortality [1,2] , decreased quality of life and psychological stress [3,4] . Maintaining weight loss is a major public health concern Lowcalorie diets are efficient in obtaining rapid and large weight reductions [5] but the lost weight is usually regained [6,7] unless targeted weight loss maintenance strategies are initiated [8] .…”
Section: Introductionmentioning
confidence: 99%
“…Obesity is related to increased morbidity and mortality [1,2] , decreased quality of life and psychological stress [3,4] . Maintaining weight loss is a major public health concern Lowcalorie diets are efficient in obtaining rapid and large weight reductions [5] but the lost weight is usually regained [6,7] unless targeted weight loss maintenance strategies are initiated [8] .…”
Section: Introductionmentioning
confidence: 99%
“…[34567] The most common causes of NCDs-related morbidity and mortality are cardiovascular disease (CVD). [8]…”
Section: Introductionmentioning
confidence: 99%
“…In 2011-2012, the prevalence of obesity in the USA was 17% in youth and 35% in adults [2] or an estimated prevalence of 13% (600 million) obese individuals worldwide [3]. As obesity is associated with a wide range of comorbid conditions [4,5], there is an urgent need for new treatment strategies. With the discovery of the potential for the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for not only lowering blood glucose but also body weight [6][7][8], a whole new perspective for GLP-1 and the GLP-1 RAs has been established.…”
mentioning
confidence: 99%